Zanolimumab (Humax-CD4), a fully human monoclonal antibody with significant clinical responses in cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 11 [cited 2025 Jul. 15];3(1). Available from: https://journals.pagepress.org/hmr/article/view/540